Innovent and Ollin Biosciences report IBI324 study data in wAMD and DME

Boston Scientific receives FDA clearance for Asurys fluid management system

GSK's bepirovirsen accepted for review in China as potential Hepatitis B functional cure

4DMedical secures EU approval for CT:VQ as EUR83m funding fuels European expansion

Aurinia Pharmaceuticals agrees to acquire Kezar Life Sciences

GXO appointed to manage NHS England bowel cancer home testing kits

Amgen reports Repatha (evolocumab) cuts risk of first major CV events by 31% in high-risk patients without known significant atherosclerosis

Lilly presents Phase 3b Taltz (ixekizumab) plus Zepbound (tirzepatide) data at AAD Annual Meeting

AROA Biosurgery completes Symphony trial in patients with diabetic foot ulcers

Novartis to acquire Excellergy in USD2bn deal

Almirall reports lebrikizumab demonstrated sustained long-term control in atopic dermatitis through four years

AstraZeneca's tozorakimab meets primary endpoints in two Phase III COPD trials

Hoth Therapeutics deploys OpenClaw AI platform for drug discovery

Insilico Medicine and Tenacia expand AI-driven R&D collaboration

Eisai and Nuvation Bio report taletrectinib MAA validated by European regulator